Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced the top line results of the SOLUTION clinical study in cystic fibrosis patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE